Patent details

EP3505179 Title: CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF

Basic Information

Publication number:
EP3505179
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP182111799
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF
French Title of Invention:
POLYPEPTIDES DE FACTEUR VIII CHIMÉRIQUES ET LEURS UTILISATIONS
German Title of Invention:
CHIMÄRE FAKTOR-VII POLYPEPTIDE UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
12/01/2013
Grant date:
08/04/2026
EP Publication Date:
03/07/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/04/2026
EP B1 Publication Date:
08/04/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/01/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/04/2026
 
 

Name:
Bioverativ Therapeutics Inc.
Address:
225 Second Avenue, Waltham MA 02451, United States (US)

Inventor

1

Name:
PETERS, Robert
Address:
United States (US)

2

Name:
JIANG, Haiyan
Address:
United States (US)

3

Name:
LIU, Tongyao
Address:
United States (US)

4

Name:
CHHABRA, Ekta, Seth
Address:
United States (US)

Priority

1

Priority Number:
201261586099 P
Priority Date:
12/01/2012
Priority Country:
United States (US)

2

Priority Number:
201261586654 P
Priority Date:
13/01/2012
Priority Country:
United States (US)

3

Priority Number:
201261667901 P
Priority Date:
03/07/2012
Priority Country:
United States (US)

4

Priority Number:
201261734954 P
Priority Date:
07/12/2012
Priority Country:
United States (US)

Classification

IPC classification:
C07K 14/755; A61K 38/37; A61K 47/62; A61P 7/04;

Publication

European Patent Bulletin

Issue number:
202615
Publication date:
08/04/2026
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/02/2027
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages